NeuroSense CEO to be Panelist at Maxim Group’s Innovations in ALS: Exploring New Treatments In Development on June 28, 2022 USA – English – USA – English – PR Newswire

NeuroSense CEO to be Panelist at Maxim Group’s Innovations in ALS: Exploring New Treatments In Development on June 28, 2022 USA – English – USA – English – PR Newswire
Source: Google NewsPublished on 2022-06-22